Litigation Details for Ferring B v. v. Watson Laboratories Inc. (Fed. Cir. 2014)
✉ Email this page to a colleague
Ferring B v. v. Watson Laboratories Inc. (Fed. Cir. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-04-17 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,066,339; 6,548,084; 6,551,616; 7,235,530; 7,947,739; 8,022,106; 8,273,795 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Ferring B v. v. Watson Laboratories Inc.
Biologic Drugs cited in Ferring B v. v. Watson Laboratories Inc.
The biologic drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Ferring B v. v. Watson Laboratories Inc. (Fed. Cir. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-05-01 | 27 | 6,051,253 A 4/2000 Zettler 6,066,339 A 512000 Stark et al. …may be divided into three doses of 6,066,339, which is expressly incorporated by reference … EXHIBIT~ 6,066,339 A 5/2000 Stark et al. …doses. As an example, a total daily dose 35 6,066,339, which is expressly incorporated by reference …infringement of the patents-in-suit in this case as well as a related patent, U.S. Patent No. 8,478,005. | External link to document | |
| 2014-05-14 | 40 | Ferring’s U.S. Patent Nos. 7,947,739 (“the ’739 patent”), 8,022,106 (“the ’106 patent”) and 8,273,795…The Asserted Patent Claims Claim 1 of the ’739 patent is illustrative of the patent claims at issue…regarding the patents at issue in this appeal, and an infringement claim regarding a different patent. …as Example 1 of the patents-in-suit, and its own ANDA documents and patent application detail …the asserted patent claims, and also meet the dissolution limitations of the patent claims. 3 | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
